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Abstract
Background: Adipocyte renewal from preadipocytes occurs throughout the lifetime and contributes to obesity. To date,
little is known about the mechanisms that control preadipocyte proliferation and differentiation. Prokineticin-2 is an
angiogenic and anorexigenic hormone that activate two G protein-coupled receptors (GPCRs): PKR1 and PKR2. Prokineticin-
2 regulates food intake and energy metabolism via central mechanisms (PKR2). The peripheral effect of prokineticin-2 on
adipocytes/preadipocytes has not been studied yet.
Methodology/Principal Findings: Since adipocytes and preadipocytes express mainly prokineticin receptor-1 (PKR1), here,
we explored the role of PKR1 in adipose tissue expansion, generating PKR1-null (PKR12/2) and adipocyte-specific (PKR1ad2/
2) mutant mice, and using murine and human preadipocyte cell lines. Both PKR12/2 and PKR1ad2/2 had excessive
abdominal adipose tissue, but only PKR12/2 mice showed severe obesity and diabetes-like syndrome. PKR1ad2/2) mice had
increased proliferating preadipocytes and newly formed adipocyte levels, leading to expansion of adipose tissue. Using
PKR1-knockdown in 3T3-L1 preadipocytes, we show that PKR1 directly inhibits preadipocyte proliferation and
differentiation. These PKR1 cell autonomous actions appear targeted at preadipocyte cell cycle regulatory pathways,
through reducing cyclin D, E, cdk2, c-Myc levels.
Conclusions/Significance: These results suggest PKR1 to be a crucial player in the preadipocyte proliferation and
differentiation. Our data should facilitate studies of both the pathogenesis and therapy of obesity in humans.
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Introduction
Obesity causes many serious diseases such as type-2 diabetes
mellitus, cardiovascular diseases and certain types of cancer, and
has contributed to increases in mortality and morbidity rates [1].
Identification of factors regulating white fat tissue growth provides
an important strategy to combat these diseases. Obesity is
characterized by an expansion of adipose tissue mass due to
hypertrophy, an increase in adipocyte size [2], and hyperplasia, an
increase in cell number [3]. The expended adipose tissue plays a
key role for the induction of insulin resistance commonly seen in
obesity [4]. The adipocytes increase in size is due to lipid
accumulation [5]. Mature adipocytes are postmitotic [6]. Thus,
adipocyte hyperplasia in adults requires the generation of new
adipocytes from precursor cells (preadipocytes) and stem cells
resident in the stromal-vascular compartment of white adipose
tissues (WATs). Preadipocytes are capable of proliferating and
differentiating into an adipose deposit [7]. Stimulation of the
proliferation of these cells may therefore result principally in an
increase in adipocyte number. In mice, preadipocytes can
proliferate and subsequently differentiate into mature adipocytes
[8]. Thus, understanding the mechanisms controlling preadipocyte
proliferation and conversion to adipocyte provides insights into the
etiology and prevention of obesity and its associated pathologies.
Prokineticin-2 is a potent angiogenic [9] and anorexigenic
hormone [10]. It binds two similar G protein-coupled receptors
(GPCRs): PKR1 and PKR2 [11]. This hormone, which is widely
distributed in mammalian tissues [12], has HIF-1 binding sites and
is induced by low oxygen levels [13]. It is involved in diverse effects
in peripheral systems, including angiogenesis in the ovary, testis
[14,15] and heart [16]. It also stimulates hematopoiesis [17] and
neurogenesis [18]. Prokineticins induce the differentiation of
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murine and human bone marrow cells into the monocyte/
macrophage lineage [19] and activate monocyte proliferation and
differentiation [20] and macrophage migration [21]. Prokineticin-
2/PKR1 restores the pluripotency of epicardial progenitor cells
and triggers the differentiation of endothelial and vascular smooth
muscle cells [16]. By binding to PKR1, prokineticin-2 directly
promotes angiogenesis, by activating MAPK and Akt [16].
Prokineticin-2 [22] is involved in appetite suppression [10] and
energy homeostasis, thermoregulation (15), via a direct hypotha-
lamic mechanism [23]. The intracranial or peripheral injection of
prokineticin-2 has been shown to reduce food intake and body
weight in lean and obese mice at the levels of hypothalamus
(central effect via PKR2) [10] and dorsal vagal complex
(peripheral effects via PKR1) [24]. However, the role of
prokineticin-2 and its receptors in adipocyte and preadipocyte
function is unknown.
PKR1 is the principal receptor expressed by preadipocytes and
adipocytes [12]. In this study, we explored the role of PKR1 in
adipocyte function, in vivo using PKR1-null (PKR12/2) and
adipocyte-specific (PKR1ad2/2) mutant mice, and in vitro, using
murine (3T3-L1) and human preadipocyte cell lines (SGBS). Here
we described multiple PKR1 functions regulates preadipocyte
proliferation and differentiation, controlling adipose tissue expan-
sion.
Materials and Methods
Ethics statement
The animal study was approved by the Animal Care and Use,
and ethics committees of the Perfecture du Bas-Rhin (Permit
Number: B67–274) with the recommendations in the Guide for
the Care and Use of Laboratory Animals of the French Animal
Care Committee, with European regulation-approved protocols.
The animal experimentation and housing were conducted at the
accredited Animal Experimentation and housing Facility of the
Institut de recherche de l9Ecole de biotechnologie de Strasbourg
(Register number: C67-218-19).
The human study was approved by the ethics committee of
Toulouse-Rangueil and Nancy-J. d’Arc Hospitals. Human adipose
tissues were collected according to the guidelines of the Ethical
Committee of Toulouse-Rangueil and Nancy-J. d’Arc Hospitals.
All subjects gave their informed consent to participate to the study
and investigations were performed in accordance with the
declaration of Helsinki as revised in 2000 (http://www.wma.
net/e/policy/b3.htm). Human subcutaneous adipose tissue sam-
ples were obtained from patients undergoing abdominal lipectomy
for plastic surgery or before a bariatric surgery and immediately
frozen in liquid nitrogen and stored at 280uC. Written informed
consent was obtained from all subjects and samples were coded
and treated anonymously.
Genetically manipulated animal models
Male PKR12/2 mice in C57BL/6 gene background were
originally made by homologous recombination [25]. For diet-
induced obesity, 6-week-old PKR1-deficient mice and their wild-
type littermates (C57BL/6) were kept in micro isolation cages and
fed a high-fat diet containing 60% fat or normal cow diet (5% fat)
(Research Diet, New Brunswick, NY) for 34 weeks. PKR1 floxed
mice [25] and aP2-CreERT2 [26] on a C57BL6/J background
were intercrossed to generate the following genotypes: PKR1L2/
L26 aP2-CreERT2(Tg/0) and PKR1L2/L26 aP2-CreERT2(0/
0). Mice in which PKR1 was inactivated after tamoxifen injection
will be referred to as PKR1ad2/2 and their controls will be
referred to as L2/L2. Tamoxifen was injected 1 mg/day (i.p.) for 5
days to the L2/L2 and PKR1ad2/2 mice at the 3 weeks of age.
The second tamoxifen injection was realized at the age of 13
weeks. All the analyses were performed when the mice were 24
and 40 weeks old. Mice were placed in metabolic cages (1 mouse/
cage) and acclimated for 2 days before the experiment. The body
weight, water and food intake, and urine volume were performed
daily for an additional 3 days. The primers utilized in these studies
for the genotyping analyses were shown in the Table 1.
Glucose tolerance test (GTT) and insulin tolerance test
(ITT)
Prior to studies, mice were fasted for 5 h. For GTT, mice
received an intraperitoneal injection of glucose (1 mg/g body
weight). In ITT studies, mice received an intraperitoneal injection
of 0.75U of insulin per kg of body weight according to methods
described elsewhere [27]. Blood samples were collected from the
tail vein (tail-snip technique) at various times after the glucose or
insulin load, as indicated. Blood glucose was immediately
determined on a Contour blood glucose monitoring system
(Bayer).
Insulin stimulation of Akt activity detected by Western
Blot assay
Animals were anaesthetized with 1% pentobarbital and were
followed by an IP injection of insulin (150 mU/g, UmalineH,
Rapide). 0 and 20 min after injection mice were scarified and the
adipose tissues were harvested for protein extraction. Extracted
proteins were transferred to nitrocellulose membranes and
immunoblotted with the Phospho Akt (Ser-473 and Thr 308)
Antibody kit (Cell Signaling Technology), following incubation
with horseradish peroxidase-conjugated goat anti-rabbit IgG.
Phosphorylated protein was visualized by enzyme-linked chemi-
luminescence (Amersham Biosciences) and quantified by scanning
laser densitometry, normalizing to total amounts of the Akt
proteins.
Histological and electron microscopy analyses
Organs were removed from 24 or 40 week-old mice, dissected
and frozen for the cutting of frozen sections (5 mm), which were
stained with Mallory tetrachrome. For electron microscopy, all
organs were fixed by and embedded in epoxy resin according to
methods described elsewhere [27].
Adipocyte diameters were analyzed on cryosectioned adipose
tissue (3 independent sections) and 6–7 pictures were taken for
each section. We counted more than 50 adipocytes per piece of
WAT, resulting in a total of 3–400 adipocytes counted per mouse
(total 3 mice). Quantification of adipocyte size was done with
ImageJ software (http://rsbweb.nih.gov/ij/). All images were
converted into binary files using a unique threshold value that
separated positively labeled cells from background.
For succinic dehydrogenase (SDH) stain, excised adipose tissues
were snap frozen in OCT compound (Sakura) and sectioned at
50 mm. Subsequent staining procedure was performed by standard
protocols [28]. The staining intensity was quantified using ImageJ
program. Microscope images were converted to gray scale and
inverted. Pixels between the threshold 95,255 were selected to
avoid the background signal, and the integrated densities were
measured.
Immunostaining analyses
Frozen tissue sections for the immunofluorescence staining of
structural proteins were fixed, blocked and stained with primary
antibodies against PECAM-1, (Santa Cruz), PKR1 (IGBMC,
PKR1 Controls Preadipocyte Function
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Illkirch), Collagen type VI (abcam pAb to collagen VI), CD 68
(Serotec), pref-1 (Abcam) and PPARc (Santa Cruz). Antibody
binding was detected by incubation with Fluorescein, Alexa 555-,
Alexa 488- and Alexa 594-conjugated secondary antibodies [27].
Finally, the nuclei were stained with DAPI. Fluorescence was
analyzed on a Leica fluorescence microscopy. The quantification
was done with Image J software, by counting 20 fields at 640
magnification per tissue section for each group of mice (at least 3
mice). The measurements of immunofluorescence intensity were
performed with a Leica TCSNT confocal microscope or
fluorescent microscope. Signal intensity was quantified on
digitalized images and calculated as the product of averaged pixel
intensity per high-power field or per dapi positive total nucleus
number. Some of the fluorescent signals were obtained with
confocal microscope and images were controlled by LEICA
software. The laser was chosen according to the sample and
compared pixel intensity and pixel distribution. These data were
analyzed using the pixel data from which background intensity
was subtracted.
Evaluation of proliferation and apoptosis
Cryosectioned mice adipose tissue samples or cultured cells were
obtained and then, apoptosis was detected by the TdT-mediated
dUTP nick end-labeling (TUNEL) assay utilizing Apoptag
flurescein in situ apoptosis detection kit (Milipore) according to
the manufacturer’s protocol [16]. Proliferation was evaluated with
Ki67 Labeling (Santa Cruz), as previously described protocol [27].
Cryosectioned mice adipose tissue samples or cells were fixed,
blocked and stained with primary antibodies against Ki67.
Antibody binding was detected by incubation with Fluorescein,
Alexa 488-conjugated secondary antibody. Cells were scored for
Tunel or Ki67-positive nuclei corresponding to DAPI stained
nucleus in the each high power field (20 minimum) containing at
least 30 nuclei at640 magnification.
For FACS analyses, epididymal WATs of 40-week-old male
mice were digested with 1 mg/ml collagenase Type IV (Sigma-
Aldrich), filtered through sterilized lens paper, and centrifuged.
Enriched adipocytes floating on the top were removed. Cell pellets
were permeabilized (20 h at 220uC in 70% ethanol). At least
16105 cells in PBS/0.5% BSA/2 mmol/liter EDTA were
incubated with fluorescein isothiocyanate (FITC)-conjugated Ki-
67 antibody. The labeled cells were analyzed by multiparameter
flow cytometry using a FACSCalibur flow cytometer and the
CellQuest Pro software (BD Bioscience).
Cell counting
Murine preadipocytes, 3T3-L1 cells (105) were obtained from
American Type Culture Collection, and cultured in DMEM, for
48 h then cell number was counted. In the other settings growth
capacity of 3T3-L1 cells was determined in which 66104 cells
were plated in DMEM containing 0.5 or 10% FBS in the presence
or absence of prokineticin-2 (peprotech) (1, 5, 10 nM). Total cell
number per well was daily counted from d 0–4 with a
hemocytometer [29]. Note that maximum effect was observed
with prokineticin-2 at 5 nM concentration.
Adipocyte differentiation by oil red O staining
Confluent 3T3-L1 were differentiated into adipocytes by the
DMEM supplemented with 0.5 mM isobutylmethylxanthine
(IBMX) (Sigma-Aldrich), 1 mM dexamethasone (Sigma-Aldrich),
and 10 mg/ml insulin (Sigma-Aldrich), as previously described
[30]. After 2 days the medium was replaced with the medium
containing only 10 mg/ml insulin. The human cell strain, derived
from an adipose depot of an infant with SimpsoneGolabieBehmel
syndrome (SGBS), was cultured as follows: briefly, confluent cells
(day 0) were induced to differentiate in DMEM/Ham’s F12 (1:1)
medium containing 0.01 mg/ml transferrin, 100 nM cortisol,
0.2 nM triiodothyronine, and 20 nM insulin. To trigger the
Table 1. Oligonucleotides used for PCR analyses.
Genes Sequence Forward (59 -.39) Sequence Reverse (59 -.39)
Beta actin CATCTTGGCCTCACTGTCCA GGGCCGGACTCATCGTACT
PPAR alpha ACGATGCTGTCCTCCTTGATG GTGTGATAAAGCCATTGCCGT
PPAR gamma CGAGAAGGAGAAGCTGTTGG GAAACTGGCACCCTTGAAAA
C/EBP alpha CAAGAACAGCAACGAGTACCG GTCACTGGTCAACTCCAGCAC
Adiponectin AATCCTGCCCAGTCATGCCGAAG TCTCCAGGAGTGCCATCTCTGCCATC
Resistin AGAAGGCACAGCAGTCTT TGTCCAGTCTATCCTTGC
Cyclin D1 GAGATTGTGCCATCCATGC CTCCTCTTCGCACTTCTGCT
Cyclin E1 TTCTGCAGCGTCATCCTCT TGGAGCTTATAGACTTCGCACA
Cdk-2 CACAGCCGTGGATATCTGG CATGGTGCTGGGTACACACT
c-Myc CCTAGTGCTGCATGAGGAGA TCTTCCTCATCTTCTTGCTCTTC
HIF1 alpha TACAAGGCAGCAGAAACCTAC TGTGCAATTGTGGCTACC
mPKR1 GCCATTGCCATTGACAGGTA TGGTGAAGTAGGCAGCTGGA
UCP CTTGTCAACACTTTGGAAAGG CCTTGGTGTACATGGACATC
GLUT 4 TGTTTTGAAGAACGGATAGG CGGATTTCTTGAGTTCAAGG
TNFalpha ACGGCATGGATCTCAAAGAC AGATAGCAAATCGGCTGACG
hPK2 CTTGCCTCTTCCACCTCAAA TGCAAGAGGAGGGAAGAGAA
hPK-R1 CGGCATTGGAAACTTCATCT GATGAGCAGGTTGGTGAGGT
Cre ATC TTC CAG CAG GCG CAC CAT TGC CCC TGT TGA CGG TGG GAG AAT GTT AAT CCA TAT TGG
L2/L2 GAC TGG ACA TCT AGT GGT AGT CAG G GGG TGT GAG GTG GGA TTA AGT CAC
doi:10.1371/journal.pone.0081175.t001
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differentiation, 25 nM dexamethasone, 500 mM IBMX and
2 mM rosiglitazone were present from day 0 to day 4. Intracellular
accumulation of lipid droplets became clearly evident at day 10.
The cells were stained with Oil Red O (0.5 g in 100 ml
isopropanol) at the day 8 for 3T3-L1, at the day 10 for SGBS
cells, to visualize the lipid accumulation. In the other settings 3T3-
L1 cells were treated with prokineticin -2 (5 nM) 10 h before
adipogenic stimuli, because the entry into S phase by 10% serum
occurs within 10 h. For quantitative analysis of Oil Red O
staining, oil red positive cells were detected and calculated as % of
total dapi positive cells in the at least 20 random fields from each
samples, using an inverted phase contrast microscope (Leica).
Images were captured at a magnification of 206 or 406 with a
digital microscope camera system. ImageJ software (National
Institutes of Health) was used to convert bright field (24 bit) images
of Oil red O stainings to 8 bit images. Threshold values were
chosen that maximize selection of the Oil red O positive tissue
while minimizing background interference. Thus, the total
number of lipid drops from each image (percent) was quantified
and normalized by dapi positive cell number [31]. Differentiation
of adipose cells was also assessed by measuring triacylglycerol
content of the homogenates, using the Triglyceride Enzymatic
PAP150 kit (BioMe’rieux, Marcy l9Etoile, France) [31].
RNA interference
The RNA interference technique was used for down-regulating
PKR1 gene expression as previously described [32]. Transfection
was performed by using siPORT Amine transfection reagent
(Ambion, Austin, TX, USA) with 10 nM siRNA for mouse PKR1
(Ambion siRNA #181827), according to the manufacturer’s
instructions (Ambion). Negative control siRNA transfection was
also performed by using non-specific siRNA (Ambion). After
48 hours medium was replaced with induction medium to induce
differentiation into mature adipocyte or to isolate RNA for
detection of PKR1 levels by PCR. In this condition reduced
expression of PKR1 lasts at least 48 h. Note that PKR1 expression
was reduced after adipogenic cocktail treatment. Thus, the down
regulation of PKR1 remained constant before and after adipo-
genic induction.
Analysis of gene expression by quantitative PCR
Total RNA was prepared from 3T3-L1 cells or collected tissues
using a Tri-Reagent (MRC, Cincinnati, OH) according to the
manufacturer’s instructions [29]. Total RNA (2-5 mg) was reverse-
transcribed with Super Script II Reverse Transcription Reagents
(Invitrogene). The resultant cDNA was subjected to real-time
quantitative PCR, in which a specific primers for mouse
adiponectin, resistin, TNFa, PPARa, PPARc, C/EBPa, cyclin
D, E, cdk2, c-Myc were used (Table 1). The real-time PCR was
carried out in an iCycler myiQ apparatus (Bio-Rad, Life Science
Research, Hercules, CA) and SYBR green (Bio-Rad). Relative
values of mRNAs were analyzed by the DDC(T) method,
normalized to GAPDH mRNA and shown as fold change in
expression over control.
Thermogenesis
Rectal temperature was measured in 40-weeks-old WT and
PKR12/2 mice [33]. Mice were caged individually and fasted for
3 h before they were placed in a room maintained in 4uC for cold-
exposure experiments. The initial temperature measurements
were performed 3 hours before cold exposure (before fasting), at
time point 0 (just before cold exposure) and after 2 hours in cold
environment.
Intestinal lipid absorption
WT and PKR12/2 mice were fasted overnight. Mice received
500 ml of olive oil by gavage. Mice were sacrificed 1 hour after
gavage feeding and tissues were harvested for histological or oil-
red oil analyses [34].
Fecal fat quantification
Mice were caged individually in metabolic cages with inserts
that permit collection and prevent ingestion of fecal material. Mice
were maintained for 3 days and feces were collected at days 2 and
3. Fat was extracted from 1 g of feces with 20 ml of chloroform/
methanol (2:1) for 20 min at room temperature as previously
described[34].
Statistic analysis
The results are expressed as means 6 SEM. Unless otherwise
noted, statistical comparisons for all experiments were performed
using Mann–Whitney (for 2 groups) and Kruskal–Wallis (for .2
groups) tests. Statistical comparisons for staining with Oil Red O
for adipocytes, CD68 macrophages, PECAM for endothelial cells,
Pref-1 for preadipocytes, Tunel and Ki67 for apoptotic nd
proliferating cells were performed using the unpaired Student t
test and ANOVA. P,0.05 was considered statistically significant
for all tests.
Results
PKR1 null mutant (PKR12/2) mice develop obesity
PKR1 null mutant (PKR12/2) mice become severely obese on
a normal chow diet with body weights ,40% higher than those of
wild-type mice at the age of 40 weeks (Fig. 1A and Fig. S1).
However, the mutant and wild-type mice consumed identical
amounts of food on the chow diet, ruling out the possibility that
PKR1 deficiency results in a greater body weight gain due to
hyperphagia (Fig. 1A, right). The epididymal fat pads (subcuta-
neous and visceral WATs) were also ,4 times heavier in the
PKR12/2 mice than in their wild-type littermates on a normal
chow diet (Fig. 1A, middle and Fig. 1B). However, there is no
difference in brown adipose tissue mass between two groups of
mice. Note that no PKR1 expression was detected in brown
tissues. We investigated whether PKR1 deficiency increased WAT
mass by the hypertrophy or by hyperplasia of white adipocytes, by
measuring the numbers and diameters of WAT in the visceral
region of PKR12/2 and wild-type mice. The staining of semi-thin
sections revealed that PKR12/2 adipocytes were smaller than
wild-type adipocytes, but that their density was higher (Fig. 1C
and 1D). However, proliferating Ki67+ cells were clearly abundant
in PKR12/2 adipose tissue (Fig. 1E and FACS analysis). Most of
the Ki67+ cells were also positive for the Pref-1 marker of
preadipocytes (Fig. 1F). Higher transcript levels for the transcrip-
tion factors involved in adipogenesis, (PPARa, PPARc alpha and
C/EBPa) and for the markers of inflammation (TNFa) and
mature adipocytes (resistin) were observed in PKR12/2 mice,
suggesting a possible increase in the conversion of preadipocytes to
adipocytes (Fig. 1G). 10% of mature PKR12/2 adipocytes
displayed ultra structural features typical of necrosis (i.e., ruptured
basal membranes, organelle degeneration), but no detectable
features of apoptosis (Fig. 1H). Small cytoplasmic lipid droplets
(Fig1H lower panel) and swollen mitochondria that had lost their
cristae (Fig1H upper panel) were also observed in the mature
PKR12/2 adipocytes. Staining for the angiogenesis marker
PECAM-1 revealed no change in the capillary network (Fig. 1I),
despite the expansion of adipocyte mass. The mutant mice had
lower levels of mitochondrial succinyl dehydrogenase (SDH)
PKR1 Controls Preadipocyte Function
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Figure 1. PKR1 null mutant mice (PKR12/2) exhibit obesity at the later age. A) Body weight (g), and WAT and pancreas (pancr) weight (g),
and food intake (g/24 h) at the age of 40 weeks (*p,0.05, n = 6). B) Representative illustration of abdominal obesity in PKR12/2 mice. C)
Representative illustration of semi-thin sections of adipocyte tissue derived from PKR12/2 and WT mice. D) Histograms show cell number and
diameter differences between these two groups of mice. E) Representative illustration of Ki67 positive cells (green) and dapi positive total cells (blue)
in adipose tissue of PKR12/2 and WT mice. Quantification of Ki67+ cell numbers in the high power field (HPF,640 objective) (*p,0.05, n = 20 HPF).
Flow cytometery for Ki67 positive nuclei in the cells that were prepared from PKR12/2 and WT type abdominal (epididymal and visceral) WATs tissue
after removal of adipocytes. F) Representative illustration and quantification of pref-1+/Ki67+ positive cells (orange) and dapi positive total cells (blue)
in adipose tissue of PKR12/2 and wild type mice (*p,0.05, n = 20 HPF,640 objective). G) qPCR analyses of transcript levels of adipogenic genes of
PKR12/2 mice over WT mice (fold increase). H) Representative illustration of electron microscopic analyses of adipose tissues derived from PKR12/2
and WT mice demonstrating cytoplasmic lipid droplets (lp) and swollen mitochondria (mtc). Nc: nucleus, bv: blood vessel. I) Illustration and histogram
shows the PECAM-1 staining and capillary formation are similar between the adipose tissues of PKR12/2 and WT mice (p,0.05, n = 20 HPF,640
objective). J) Illustration and histogram shows the succinyl dehydrogenase (SDH) staining changes between the adipose tissues of PKR12/2 and WT
mice (*p,0.05, n = 20 HPF,640 objective). K) Western blots analyses reveal a high level of HIF-1a levels in PKR12/2 mice (*p,0.05, n = 3).
doi:10.1371/journal.pone.0081175.g001
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activity (Fig. 1J), and higher protein levels of hypoxia-inducible
factor-1, a marker of hypoxia (Fig. 1K), clearly demonstrating the
occurrence of hypoxia in the mature PKR12/2 adipocytes with
defective capillary formation.
PKR1 null mutant mice displayed diabetes-like disorders
We then investigated possible impairment of the insulin
response in hypoxic PKR12/2 WAT tissues. We found that the
insulin-stimulated phosphorylation of Akt kinase at the threonine
308 and serine 478 residues was severely attenuated in PKR12/2
WAT tissues (Fig. 2A left). We analyzed whether PKR1-deficient
mice displayed changes to glucose homeostasis and metabolism.
Glucose and insulin tolerance tests (ITT) showed that these
animals were significantly less able to handle glucose loading than
wild-type mice, at the age of 40 weeks. In the glucose tolerance test
(GTT), PKR1-deficient mice displayed impaired glucose toler-
ance, with higher blood glucose concentrations 20, 40, 60, 90 and
120 min after glucose administration than were recorded for wild-
type mice (Fig. 2B left). Insulin sensitivity was also significantly
lower in PKR1-null mutant mice than in wild-type mice (Fig. 2B
right). An impaired glucose tolerance was also observed in
PKR12/2 mice at the age of 15 weeks (Fig. S2). No significant
differences in food intake and net energy expenditure (thermo-
genesis) (Fig. S6A) and changes in the expression of energy
metabolism-related genes in the skeletal muscle (Fig. S6B).
Jejunum of PKR12/2 mice displayed no significantly higher
levels of lipid absorption one hour after gavage with oil (Fig. S6C).
The levels of lipid excretion in the feces did not alter for PKR12/2
mice and wild-type mice on the chow diet (Fig. S6D), suggesting
that PKR12/2 mice did not show abnormal absorption of
calories.
Next we investigated the effect of a dietary fat composition on
the obese phenotype, by feeding the wild type and PKR12/2
mutant mice a high-fat diet. The high-fat diet greatly decreased
the differences in body weight between the two groups, due to a
massive increase in the body weight of wild-type mice (Fig. 2C).
The PKR12/2 and wild-type mice ingested identical amounts of
food on the high-fat diet (2.5660.35 and 2.960.39 g/day,
respectively). Consistent with these findings, mutant and wild-type
mice had similar GTT and ITT results 34 weeks after high-fat diet
treatments, due to a diabetes-like increase in glucose and insulin
tolerance in the wild-type mice (Fig. 2D). Both groups exhibited
Figure 2. PKR1 null mutant mice exhibit a diabetes-like syndrome. A) Western blot analyses on lysates derived from the adipose tissue of
both group of mice 0 or 20 min after i.p. 0.75U/I insulin injections. Western blot analyses revealed that insulin-stimulated phosphorylation of Akt (at
serine and threonine) were significantly lower in PKR12/2 adipose tissue as compare to wild (WT) adipose tissue (* p,0.05, n = 3). B) Glucose
tolerance (GTT) and Insulin tolerance tests (ITT) in 40 weeks old mice. PKR12/2 mice did not tolerate glucose load and displayed impaired ITT (*
p,0.05, n = 8). C) Body weight increases in HFD-fed and NFD-fed mice. * shows a significant difference between NFD-fed PKR12/2mice and WT mice,
n = 8. t shows difference between HFD-fed and NFD-fed WT mice (blue). D) GTT and ITT in HFD-fed mice at the age of 40 weeks. No significant
alteration was observed between the groups, due to severe increase in GTT and ITT of WT mice treated with HFD (* p,0.05, n = 8). E) Representative
illustration of semi-thin sections of adipocyte tissue derived from PKR12/2 and WT mice after HFD feeding showing the hypertrophic adipocytes in
both groups (640). F) Histogram shows cell numbers and diameters are similar between these two groups of mice (ns = no significance, p.0.05,
n = 20).
doi:10.1371/journal.pone.0081175.g002
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hypertrophic visceral adipocytes (Fig. 2E) without alterations in
cell number and diameter (Fig. 2F).
Adipocyte specific loss of PKR1 in mice exhibit enhanced
abdominal adiposity
To eliminate an endothelial-adipocyte interaction and possible
central regulation of the body weight in mutant mice, we generate
tamoxifen-inducible adipocyte/preadipocyte-specific PKR1
knockout mice (Fig. S3A, B and C). PKR1ad2/2 mice had a
1362% higher body weight (Fig. 3B left) and 1.5 times higher
epididymal mass (Fig. 3B middle) and an increased number of
adipocytes at the age of 24 weeks (Fig. 3A and 3B right). The
PKR1ad2/2 and L2/L2 mice ingested similar amounts of food
(4.5660.35 and 4.960.39 g/day, respectively). Semi-thin
sections and electron microscopy showed interstitial macrophage
deposition in PKR1ad2/2 adipose tissue, which was confirmed by
macrophage-specific, CD68 staining (Fig. 3A, C and D). Capillary
formation, as detected by PECAM-1 staining, was also elevated in
PKR1ad2/2 adipose tissues (Fig. 3E). The PKR1ad2/2 adipose
tissues contained a 3 times higher number of Ki67+/Pref-1+ cells
(Fig. 3F). We then determined the number of newly generated
adipocytes by double-immunostaining for Ki67 and PPARc.
Almost 14% of the Ki67+ cells also expressed PPARc (Fig. 3G),
indicating that the adipocytes concerned had recently been
generated by preadipocyte proliferation in the PKR1ad2/2 adipose
tissues. (The specificities of antibodies for pref-1 and PPARc were
tested on adipose tissues and shown in Fig. S3D). Thus, adipose
tissue plasticity in PKR1ad2/2 mice induces higher WAT mass by
increasing preadipocyte proliferation and conversion to adipocytes.
Albeit the initial glucose levels were higher in 24 week-old mice
Figure 3. Abdominal obesity in PKR1ad2/2 mice is due to preadipocyte proliferation and differentiation. A) Representative illustration
of semi thin analyses of adipose tissues derived from control (L2/L2) and PKR1ad2/2 mice. Blue shows macrophage accumulation. B) Body (g) and
WAT weight (g), and adipocyte number of the PKR1ad2/2 and L2/L2 mice (*p,0.05, n = 6). C) Representative illustration of electron microscopic
analyses of adipose tissues derived from PKR1ad2/2 and L2/L2 mice, showing macrophage deposition in PKR1ad2/2 mice. D) Macrophage specific
CD68 staining and quantification of macrophages on cryosectioned adipose tissues derived from PKR1ad2/2 and L2/L2 mice (*p,0.05, n = 20 HPF,
640 objective). E) Illustration and histogram shows the PECAM-1 staining and capillary formation changes between the adipose tissues of PKR1ad2/2
and L2/L2 mice (*p,0.05, n = 20 HPF,640 objective). F) Representative illustration and quantification of pref-1+/Ki67+ positive cells (orange) and dapi
positive total cells (blue) in adipose tissue of PKR1ad2/2 and L2/L2 mice (*p,0.05, n = 20, HPF,640 objective). G) Representative illustration and
quantification of PPARc+/Ki67+ positive cells (orange) and PPARc/dapi positive total cells (violet) in adipose tissue of PKR1ad2/2 and L2/L2 mice
(*p,0.05, n = 20 HPF,640 objective). H) GTT and ITT in 24 weeks old mice (*p,0.05, n = 6).
doi:10.1371/journal.pone.0081175.g003
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PKR1ad2/2 mice, the glucose clearance was similar to control
group in response to glucose loading at the age of both 24 (Fig. 3H)
and 40 weeks (Fig. S4). The ITT remained similar in both groups at
the both 24 and 40 week-old ages (Fig. 3H and Fig. S4).
Prokineticin-2 inhibits proliferation of 3T3-L1 cells
To gain further insights into the functional interactions
governing adipose tissue expandability, we investigated whether
PKR1 has a cell-autonomous role in preadipocytes 3T3-L1. For
control 3T3-L1 cells, the number of cells began to increase about
24 h after induction with 10% FCS. However, there were fewer
cells 24–72 h after induction following prokineticin-2 (5 nM or
10 nM) treatment than after treatment with 10% FCS alone
(Fig. 4A). We then investigated the cell cycle by Ki67 staining
(Fig 4B and 4C). Entry into S phase increased within 10 h, in cells
grown in 10% FBS but not in cells grown in 0.5% FCS. However,
the increase in the number of Ki67+ cells induced by 10% FCS
was inhibited by prokineticin-2 treatment. No differences were
observed between prokineticin-2-treated and control cells in
culture medium supplemented with 0.5% FCS, indicating that
prokineticin-2 had no cytotoxic effect (Fig. 4B). A direct apoptotic
effect of prokineticin-2 was excluded by TUNEL staining, which
revealed no detectable apoptosis 48 hours after treatment of the
cells with prokineticin-2 (Fig. 4D). These data suggested that 3T3-
L1 cells were at a similar degree of confluence and that there was
no cytotoxicity or apoptosis induction in response to prokineticin-2
treatment. Strikingly, prokineticin-2 induced a marked decrease in
the expression of molecular markers of the cell cycle, such as cyclin
E, cyclin D (within 10 hours), Cdk2 and c-Myc (within 48 hours)
as compare to 10% FCS alone (Fig. 4E). Pretreatment of the 3T3-
L1 cells with prokineticin-2 also downregulated the cell cycle gene
expression 48 hours after the administration of an adipogenic
cocktail (insulin, dexamethasone and isobutylmethylxanthine)
(Fig. 4F). Prokineticin-2 mediated this effect was completely
abolished after acute PKR1 knockdown, achieved through the use
of an siRNA targeting PKR1. From day 48, PKR1 mRNA levels
were 70% lower after transfection with PKR1 siRNA than after
transfection with a nonspecific siRNA (Fig. S5A and B).
Prokineticin-2 inhibits adipogenic differentiation of
preadipocytes
To next explore the in vitro role of prokineticin 2 in conversion of
preadipocyte to adipocyte, the 3T3-L1 cells were grown to confluence
and their differentiation into adipocytes was induced with an
adipogenic cocktail, following treatment of the cells with prokineti-
cin-2 or vehicle. The prior treatment of the 3T3-L1 cells with
prokineticin-2 (5 nM) induced a significant decrease in adipogenic
cocktail-mediated lipid accumulation (Fig. 5A and histogram) and
TG accumulation (Fig. 5C).We evaluated the consequences of PKR1
depletion for preadipocyte differentiation further, by studying the
effects of prokineticin-2 on 3T3-L1 adipogenesis after acute PKR1
knockdown, achieved through the use of an siRNA targeting PKR1
(Fig. S5A). In these conditions, spontaneous adipocyte formation
was observed in 3T3-L1 cells transfected with an siRNA targeting
PKR1. The prokineticin-2-mediated inhibition of adipogenesis
was completely abolished, suggesting a role for PKR1 in this process
(Fig. 5B and histogram). Accordingly, in the presence of PKR1,
prokineticin-2 induced a marked decrease in the expression of
molecular markers of mature adipocytes, such as adiponectin and
resistin (Fig. 5D) and significantly decreased mRNA levels for
PPARa, PPARc alpha and C/EBPa (Fig. 5E). Prokineticin-2 also
inhibits human preadipocyte cell strain SGBS conversion to
adipocyte 10 days after adipogenic induction (Fig. 5F left and middle
panel). Interestingly, transcript levels of human PKR1 (right panel)
Figure 4. Prokineticin-2 inhibits proliferation of 3T3-L1 cells. A)
10% FCS increased cell numbers within 24 h as compare to cell
numbers in 0.5% serum treated cells reaching to maximum within 4
days. Treatment of the cells with prokineticin-2 (5 nM) significantly
reduced cell numbers as compare to that of 10% FCS alone. B) Ki67
positive proliferating cells in S phase were increased approximately 2
times with 10% FCS treatment of the 3T3-L1 cells (**p,0.05, n = 20).
Pretreatment of the cells with prokineticin-2 completely abolished Ki67
positive cell number (*p,0.05, n = 4). C) Representative illustration of
Ki67 positive cells (green) and dapi positive total cells (blue) in control
(0.5%FCS), 10%FCS and PK2+10%FCS groups (HPF,640 objective). D)
Representative illustration of Tunel positive cells (green) and dapi
positive total cells (blue) in each group. No detectible apoptotic cells
were observed in either group (n = 20, HPF, 640 objective). E) qPCR
analyses for cycling gene expression 10 hours (left) and 48 hours after
10% FCS and 10% FCS+Prokineticin-2 treatment. Transcript of Cyclin D
and E levels (fold increase) were reduced 10 h after treatment of the
prokineticin-2, whereas cdk2 and c-Myc were reduced 48 h after
prokineticin-2 treatment (*p,0.05, n = 4) as compare to that of 10% FCS
alone. F) Histogram shows quantification of transcript levels for cyclin E,
D and cdk2 48 after adipogenic cocktail (AC) treatment following
prokineticin pretreatment for 10 hours in 3T3-L1 cells as compare to
that of vehicle (n = 5, * different from vehicle, ** different from AC,
p,0.05).
doi:10.1371/journal.pone.0081175.g004
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were significantly reduced in obese visceral and subcutaneous human
tissues. Together, these in vitro data provide a convincing demonstra-
tion that PKR1 plays a key role in suppressing preadipocyte
conversion to adipocytes.
Discussion
The identification of factors involved in white fat tissue growth
is important to elucidate the etiology of obesity. Albeit recent
studies have provided insights into the anorexigenic and angio-
genic properties of prokineticin-2, its physiological functions in
preadipocytes and adipocytes are unknown. In this study, we
provide in vivo and in vitro evidence for distinct roles of prokineticin
receptor-1 (PKR1) in maintenance of proliferation and conversion
of preadipocytes to adipocytes, controlling abdominal adipocyte
numbers and adipose tissue mass.
Figure 5. Prokineticin-2 inhibits preadipocyte conversion to adipocytes. A) Oil-red O staining of 3T3-L1 cells treated with control (ctr),
adipogenic cocktail (AC) for 8 days or pretreated with 5 nM of prokineticin-2 (+PK-2) 10 h before AC treatment (n = 20, *p,0.05, HPF,640 objective).
B) In the PKR1 knockdown 3T3-L1 cells (siRNA-PKR1), prokineticin-2 (5 nM) pretreatment did not able to inhibit adipogenesis induced by AC.
Histogram shows pretreatment of adipocytes with prokineticin-2 reduced number of adipocytes detected by Oil red staining in the control siRNA
transfected 3T3-L1 cells but not in the PKR1 siRNA transfected cells (n = 20, *p,0.05, HPF,640 objective). C) Triglyceride (TG) accumulation in the cell
lysates. * shows PK2 significantly diminished AC effect (n = 3, p,0.05). D) qPCR analyses show increased levels of mature adipocyte markers, resistin
and adiponectin by AC that was inhibited by prokineticin-2 as compare to that of AC (n = 3, p,0.05). E) qPCR analyses reveal that PPARa, PPARc and
C/EBPa, were significantly reduced by prokineticin-2 pretreatment as compare to that of AC (n = 3, p,0.05). F) Representative illustration and
histogram shows that prokineticin-2 reduced human preadipocyte SGBS cell differentiation into adipocytes and TG accumulation induced by AC
(n = 3, p,0.05). Quantitative PCR analyses show that transcript levels of human PKR1 (right panel) were reduced in obese visceral and subcutaneous
human tissues (n is indicated in the figure, *p,0.05).
doi:10.1371/journal.pone.0081175.g005
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Both PKR12/2 and PKR1ad2/2 mice displayed abdominal
obesity, but only PKR12/2 mice had peripheral obesity accom-
panied by a diabetes-like syndrome, suggesting non-adipocyte
PKR1-mediated events also contribute to development of periph-
eral obesity with diabetes-like syndrome. Angiogenesis and
adipogenesis interact reciprocally via paracrine signaling systems
in the development of adipose tissue [35]. In PKR12/2 mutants,
the development of the new capillaries was obstructed due to loss
of angiogenic PKR1 in endothelial cells as well. Therefore, the
reciprocal regulation of adipogenesis via angiogenesis is impaired
in the PKR12/2 mice, creating a hypoxic environment. High
levels of HIF1a, an indicator of hypoxic stresses, in PKR12/2
adipocytes may also contribute to impaired adipocyte insulin
signaling [36]. Consistently, PKR12/2 WATs displayed impaired
Akt phosphorylation in response to insulin. PKR1 deficient mice
were obese and had poorer GTT and ITT responses than wild-
type mice. In contrast to PKR12/2 mice, PKR1ad2/2 mice had
higher levels of capillary formation in fat tissues, indicating, the
reciprocal regulation of adipogenesis via angiogenesis is not
impaired in the PKR1ad2/2 mice. Moreover, glucose and insulin
tolerance remained unaffected in the PKR1ad2/2 mice, indicating
that a damaged endothelial-adipocyte interaction may involve in
the impaired insulin response in PKR1-null mutant adipocytes.
The obese phenotype of PKR12/2 mice did not seem to be
modified by dietary fat content, because the high-fat diet resulted
in smaller differences in body weight and GTT and ITT
responses, due to the massive increase in body weight observed
in wild-type mice. However, high-fat diet promoted hypertrophy
in the both PKR12/2 and wild adipocytes, indicating that high
calorie intake is the key factor in conversion of hyperplasia to
hypertrophy in PKR12/2 adipocytes.
It seems unlikely that the hypothalamic control of energy
metabolism is involved in the adipocyte hyperplasia observed in
PKR1-null mice. PKR2, which is strongly expressed in the
hypothalamus, is responsible for the central anorexic and
thermoregulatory effect of prokineticin-2 [10]. Chronic continuous
infusion of PK2 via the brainstem significantly reduced body
weight and food intake in a mouse model of human obesity
without altering energy expenditure [37]. Central regulation of the
body weight was eliminated in our PKR1 ad-/- mice that also had
an increase in abdominal fat mass accumulation, due to
accelerated preadipocyte proliferation promoting the formation
of new adipocytes. Accordingly, preadipocyte hyperplesia in the
adipose tissue [38] exacerbates the accumulation of white
adipocytes, and is also a key event in the development of some
types of obesity [39]. In this study, we also discovered that PKR1
also has essential functions in controlling preadipocyte prolifera-
tion largely through the downregulation of cell cycle genes (cyclin
D, E, cdk2, c-Myc). Adipocytes exhibit continual turnover in adult
humans [5]. Increases in adipocyte number during aging have
been implicated in the severity of obesity in the elderly [40]. The
undifferentiated adipocyte precursors, preadipocytes residing in
adipose tissue vascular stroma are capable of proliferating and
differentiating into an adipose deposit in response to obesogenic
triggers [41]. Recently loss of necdin in mice has been shown to
promote a hyperplasic adipocyte due to increase in preadipocyte
proliferation and differentiation [42]. Postconfluent DNA replica-
tion, cell division and cell proliferation during mitotic clonal
expansion are required for initiation of the transcriptional cascade
for preadipocyte differentiation [43]. Prokineticin-2 inhibited not
only mouse embryonic preadipocyte but also adult human
preadipocyte conversion to adipocyte. We also reported here that
the expression of prokineticin-2 (Fig. S7) and its receptor PKR1
was altered in human WAT tissues. Possible mutations on these
genes in human obesity remain to be determined.
A number of angiogenic factors, including epidermal growth
factor, platelet-derived growth factor BB [44], basic fibroblast
growth factor [45] and heparin-binding epidermal growth factor-
like growth factor (HB-EGF) [46], inhibit the conversion of
preadipocytes to adipocytes [47], much like we find with
prokineticin-2.
Conclusively, this novel function of PKR1 as a major suppressor
of preadipocyte proliferation and conversion to adipocytes will
expand our knowledge on factors regulating adipocyte expansion
in the alarming world-wide trend toward increasing obesity and its
associated pathologies. Preadipocyte replication represents a new
mechanism for expansion of fat mass in cases of human obesity
and reducing preadipocyte replication may represent a new
avenue of therapeutic intervention against obesity [48]. As 40% of
drugs target GPCRs [49]PKR1 could be an effective target for
treatment or prevention of obesity.
Study Limitations: Recent studies suggest preadipocytes can
differentiate to macrophages, dedifferentiate from adipocytes or
macrophages, and differentiate back to adipocytes [50]. Since aP2-
CreERT2 line has been found to induce recombination in the
adipose tissue, capillary endothelium in the heart and in
intermyofibrillar cells in the skeletal muscle, but not in macro-
phages in adipose tissue [51], thus we can exclude effect of
macrophage on the observed phenotype of PKR1ad2/2 mice. Our
data show that the reciprocal regulation of adipogenesis via
angiogenesis is not impaired in the PKR1ad2/2 mice, eliminating
possible contribution of endothelial cells in the PKR1ad2/2 mice.
The contribution of the endothelial-PKR1 signaling on regulation
of metabolic homeostasis remains to be investigated.
Supporting Information
Figure S1 40 weeks old PKR12/2 null mutant mice
exhibit hypoxic adipocytes. Representative illustration show-
ing increased body weight of PKR12/2mice (left) compare to wild
type (right).
(TIF)
Figure S2 Metabolic changes on PKR12/2 null mutant
mice at the 15 week-old age. GTT test shows PKR1-deficient
mice have abnormal glucose clearance, beginning at 40 min
postglucose treatment as compare to age matched wild type mice
(n = 8).
(TIF)
Figure S3 Generation of PKR1ad2/2 mice and Immu-
nostaings on adipose tissues. A) Representative genotype
analysis of PKR1ad2/2 mice. Genomic DNA was amplified with
oligonucleotide primers detecting aP2-Cre and PKR1lox/lox alleles.
PKR1ad2/2mice harbor the aP2-Cre transgene and are homozy-
gous for the PKR1 floxed allele (PKR1lox/lox). Control mice (L2/L2)
are aP2-Cre negative and they are PKR1lox/+. B) RT-PCR analyses
on RNAs extracted from adipose tissue revealed that PKR1ad2/2
mice had lower Pkr1levels after tamoxifen treatment. C) Represen-
tative illustration of loss of PKR1 protein in the adipose tissue of
PKR1ad2/2 mice by immunostaining of the cryosectioned adipose
tissue with PKR1 antibody. D) Representative illustration of
immunostatining of PKR1ad2/2adipocytes with dapi, Ki67 and
pref-1 antibodies and corresponding secondary antibodies (upper).
Pref-1 and PPARc antibody stainings of the adipose tissues without
secondary antibodies show no non-specific stainings of the adipose
tissues with the first antibodies.
(TIF)
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Figure S4 Glucose clearance after glucose and insulin
treatment of 40 weeks old PKR1ad2/2mutant mice. GTT
test showed that glucose clearance in PKR1ad2/2 mice was similar
to control group in response to glucose loading at the age of 40
weeks (left). The ITT remained similar in both groups at the 40
week-old ages (n = 6, p.0.05) (right).
(TIF)
Figure S5 Prokineticin-2 mediated proliferation rate in
3T3-L1 cells, expressing low level of PKR1. A) Represen-
tative illustration of PCR analyses revealed that siRNA for PKR1
significantly reduced PKR1 expression 48 hours after siRNA-
PKR1 transfection. Histogram shows quantification of the PKR1
expression levels in each group (n= 3, *p,0.05). siRNA NS: non-
specific siRNA, siRNA PKR1: siRNA for PKR1. B) PK-2 was not
able to inhibit proliferation induced by 10% FCS for 3 days in the
3T3-L1 cells transfected with siRNA for PKR1 (n= 3, *p,0.05
different then initial 0 time). In the 3T3-L1 cells transfected with
siRNA-NS, PK-2 inhibits % FCS induced proliferation rate
(*p,0.05 different then initial 0 time ** p,0.05 different than
10% serum).
(TIF)
Figure S6 Thermogenesis, expression profiles of energy
metabolism-related genes in the muscle and lipid
absorption in PKR12/2 null mutant mice. A) Body
temperature of PKR1-deficient (PKR12/2) and wild (WT) mice
(n = 6), 3 hours before cold exposure (room temperature), the time
of cold exposure (0) and 2 hours after cold (4uC) exposure. B)
Total RNA was extracted from the muscle of 40-week-old mice.
qRT-PCR was performed using primers listed in Table 1. The
values in the muscle were normalized with those of b-actin. No
statistically significant differences were noted between WT+/+ and
PKR12/2 mice (p.0.05, n = 3). PPARs, peroxisome proliferators-
activated receptor; GLUT4, glucose transporter type 4; UCP,
uncoupling protein. All data are presented as mean6 SEM (n=4).
C) Representative of semi-thin analyses of Jejunum derived from
mutant and wild type mice 20 min after oil (vegetable oil) gavages
indicating slightly higher levels of lipid absorption in the jejunum
of PKR12/2 mice one hour after gavage with oil. C)
Quantification of intestinal lipid levels after oil-red staining
revealed a similar oil-red staining between the groups. D) The
intestinal lipid/feces lipid ratio was not significantly altered
between the groups (n = 6, p,0.05).
(TIF)
Figure S7 Prokineticin-2 and its receptor PKR1 expres-
sion in Human adipose tissues. Quantitative PCR analyses
show transcript levels of prokineticin-2, a ligand were increased in
obese human WAT tissues.
(TIF)
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